Impact of heavy proteinuria (>1 g/d) following renal transplantation.
Kim
S C
SC
Department of Surgery, Ulsan University and Asan Medical Center, Seoul, South Korea.
Kang
C H
CH
Kim
S K
SK
Jang
H J
HJ
Kim
T H
TH
Jung
J G
JG
Han
D J
DJ
D000293:Adolescent; D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D015415:Biomarkers / Q000652:urine; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005921:Glomerulonephritis / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000473:pathology / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D011507:Proteinuria; D012008:Recurrence; D012189:Retrospective Studies; D013997:Time Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone